Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Potrero Medical

Potrero Medical
2012 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Series C2 LATEST DEAL TYPE
$11.7M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of predictive health monitoring system designed to improve patient care using artificial intelligence and machine insights. The company's platform monitors the urine output and core body temperature, in degrees Fahrenheit and degrees Celsius and also measures intra-abdominal pressure, assisting physicians with early intervention of life threatening events, such as Acute Kidney Injury (AKI).

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 26142 Eden Landing Road
  • Hayward, CA 94545
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Potrero Medical’s full profile, request a free trial.

Potrero Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C2) 12-Jul-2019 $11.7M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 09-Jul-2018 000.00 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series B) 07-Aug-2017 00.000 000.00 000.00 Completed Generating Revenue
3. Grant 000 00.00 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 23-May-2014 $3.9M $3.9M 000.00 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Potrero Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series B 8,457,337 $0.000100 $0.03 $1.12 $1.12 1x $1.12 10.67%
Series A 12,241,634 $0.000100 $0.03 $0.49 $0.49 1x $0.49 15.45%
To view this company’s complete Cap Table, request access »

Potrero Medical Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boston Scientific Failed Transaction (M&A) Marlborough, MA 00000 000000&0
000000000 0000000 Venture Capital-Backed Guilford, CT 00 00000 00000000000 00000
00 0000000 0000000 Formerly PE-Backed Franklin Lakes, NJ 000000000000
00 0000000000 Corporation Chicago, IL 00000 00000000
0000000 0000000000 Corporation Erlangen, Germany 00000 00000000
To view this company’s complete list of competitors, request access »

Potrero Medical Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Green Park & Golf Ventures Venture Capital Minority 000 0000 000000 0
GT Healthcare Capital Partners Other Minority 000 0000 000000 0
Sonder Capital Venture Capital Minority 000 0000 000000 0
A.G. Hill Partners Growth/Expansion Minority 000 0000 000000 0
Barshop Ventures Family Office Majority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Potrero Medical Executive Team (13)

Name Title Board
Seat
Contact
Info
Joseph Urban President, Chief Executive Officer & Board Member
Saheel Sutaria Chief Technology Officer
Leslie Jaluria Associate General Counsel & Director of Human Resources
Sanjay Banerjee Vice President of Quality, Regulatory, & Clinical
Rebecca Lin Vice President of Strategy & Global Business Development

6 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

Potrero Medical Board Members (9)

Name Representing Role Since Contact
Info
Alan Chesler Self Board Member 000 0000
Brian Foley Self Board Member 000 0000
Carter Meyer JD Scientific Health Development Board Member 000 0000
Daniel Burnett MD Self Founder & Chairman 000 0000
David Greenberg Potrero Medical Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »